These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15132984)

  • 1. Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles.
    Nemes Z; Devreese B; Steinert PM; Van Beeumen J; Fésüs L
    FASEB J; 2004 Jul; 18(10):1135-7. PubMed ID: 15132984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
    Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
    Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
    Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains.
    Doss-Pepe EW; Chen L; Madura K
    J Biol Chem; 2005 Apr; 280(17):16619-24. PubMed ID: 15718234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
    Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y
    Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies.
    Nemes Z; Petrovski G; Aerts M; Sergeant K; Devreese B; Fésüs L
    J Biol Chem; 2009 Oct; 284(40):27252-64. PubMed ID: 19651786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
    Björkdahl C; Sjögren MJ; Zhou X; Concha H; Avila J; Winblad B; Pei JJ
    J Neurosci Res; 2008 May; 86(6):1343-52. PubMed ID: 18061943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.
    Norlund MA; Lee JM; Zainelli GM; Muma NA
    Brain Res; 1999 Dec; 851(1-2):154-63. PubMed ID: 10642839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
    Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress proteins in Alzheimer's disease.
    Smith RC; Rosen KM; Pola R; Magrané J
    Int J Hyperthermia; 2005 Aug; 21(5):421-31. PubMed ID: 16048839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent neuropathology of parkinsonian syndromes].
    Duyckaerts C; Verny M; Hauw JJ
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prion protein in human neurodegenerative disorders.
    Kovacs GG; Zerbi P; Voigtländer T; Strohschneider M; Trabattoni G; Hainfellner JA; Budka H
    Neurosci Lett; 2002 Sep; 329(3):269-72. PubMed ID: 12183028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
    Iwai A
    Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease.
    Terni B; Rey MJ; Boluda S; Torrejón-Escribano B; Sabate MP; Calopa M; van Leeuwen FW; Ferrer I
    Acta Neuropathol; 2007 Apr; 113(4):403-16. PubMed ID: 17237936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
    Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
    J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam.
    Yamazaki M; Arai Y; Baba M; Iwatsubo T; Mori O; Katayama Y; Oyanagi K
    J Neuropathol Exp Neurol; 2000 Jul; 59(7):585-91. PubMed ID: 10901229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
    Lee VM; Giasson BI; Trojanowski JQ
    Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derlin-1-immunopositive inclusions in patients with Alzheimer's disease.
    Honjo Y; Ito H; Horibe T; Shimada H; Nakanishi A; Mori H; Takahashi R; Kawakami K
    Neuroreport; 2012 Jul; 23(10):611-5. PubMed ID: 22627700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.